Background: There were limited data on the risk of post-polypectomy bleeding (PPB) in patients on direct oral anticoagulants (DOAC). We aimed to evaluate the PPB and thromboembolic risks among DOAC and warfarin users in a population-based cohort.
Methods: We performed a territory-wide retrospective cohort study involving patients in Hong Kong from 2012 to 2020.